Curing the highcost-syndrome
The Health Ministry's announcement last week that it is working on a proposal to cap the prices of more than 1,000 essential medicines is welcome, though the move is long overdue. For a long time, the question of drugs has been a bone of contention between Malaysian health activists and cons...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2006
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/33411/ http://eprints.usm.my/33411/1/DZUL323.pdf |
| Summary: | The Health Ministry's announcement last week that it is working on a proposal to cap the prices of more than
1,000 essential medicines is welcome, though the move is long overdue.
For a long time, the question of drugs has been a bone of contention between Malaysian health activists and
consumers. The last time Malaysia discussed this issue was almost a decade ago but it was of little avail.
Maybe this time it will be different.
A survey recently (NST, May 9) showed that many Malaysians pay exorbitant prices for their medicines. In
fact, drug prices in Malaysia are far above the international reference pricing, a guide on how much medicine
should cost.
The ministry's list of essential medicines will include antibiotics, aspirin and other painkillers, as well as
medicines for high blood pressure and depression. |
|---|